Jörg Eder

3.9k total citations · 2 hit papers
41 papers, 2.4k citations indexed

About

Jörg Eder is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jörg Eder has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Oncology. Recurrent topics in Jörg Eder's work include NF-κB Signaling Pathways (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Enzyme Structure and Function (4 papers). Jörg Eder is often cited by papers focused on NF-κB Signaling Pathways (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Enzyme Structure and Function (4 papers). Jörg Eder collaborates with scholars based in Switzerland, Germany and Austria. Jörg Eder's co-authors include Alan R. Fersht, Richard Sedrani, Christian Wiesmann, Fabien Vincent, Jonathan A. Lee, John G. Moffat, Marco Prunotto, Michael Rheinnecker, Bruno Martoglio and Bernd Gerhartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jörg Eder

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Opportunities and challenges in phenotypic drug discovery: an industry perspective

2017 571 citations John G. Moffat, Fabien Vincent et al. Nature Reviews Drug Discovery profile →
The discovery of first-in-class drugs: origins and evolution

2014 328 citations Jörg Eder, Richard Sedrani et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Eder Switzerland	22	1.5k	367	348	305	268	41	2.4k
M. Sundström Sweden	23	2.4k 1.5×	255 0.7×	296 0.9×	326 1.1×	293 1.1×	40	3.4k
Andrew M. Petros United States	32	3.4k 2.2×	356 1.0×	454 1.3×	659 2.2×	294 1.1×	60	4.4k
Alfredo G. Tomasselli United States	32	2.3k 1.5×	670 1.8×	181 0.5×	503 1.6×	309 1.2×	72	4.1k
Ashley C. Stuart United States	7	2.2k 1.5×	301 0.8×	213 0.6×	207 0.7×	482 1.8×	8	2.9k
V. Kinzel Germany	31	2.6k 1.7×	175 0.5×	238 0.7×	433 1.4×	377 1.4×	126	3.5k
F. Niesen United Kingdom	19	2.7k 1.7×	209 0.6×	186 0.5×	422 1.4×	443 1.7×	25	3.5k
Christina Kiel Spain	26	2.6k 1.7×	509 1.4×	195 0.6×	329 1.1×	264 1.0×	60	3.4k
Thomas O’Brien United States	31	2.7k 1.7×	341 0.9×	225 0.6×	743 2.4×	133 0.5×	62	3.6k
Jeffrey R. Huth United States	26	2.2k 1.4×	637 1.7×	281 0.8×	156 0.5×	254 0.9×	40	3.3k
Brian S. Chang United States	8	2.7k 1.8×	123 0.3×	482 1.4×	551 1.8×	118 0.4×	9	3.1k

Countries citing papers authored by Jörg Eder

Since Specialization

Citations

This map shows the geographic impact of Jörg Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Eder more than expected).

Fields of papers citing papers by Jörg Eder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Eder. The network helps show where Jörg Eder may publish in the future.

Co-authorship network of co-authors of Jörg Eder

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Eder. A scholar is included among the top collaborators of Jörg Eder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Eder. Jörg Eder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schubart, Anna, Stefanie Flohr, Tobias Junt, & Jörg Eder. (2022). Low‐molecular weight inhibitors of the alternative complement pathway. Immunological Reviews. 313(1). 339–357. 20 indexed citations

Dekker, Carien, Henri Mattes, Michael Wright, et al.. (2021). Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition. Journal of Molecular Biology. 433(24). 167309–167309. 101 indexed citations

Heiser, Diane, P. Erbel, Achim Schlapbach, et al.. (2021). Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1. Biochemical and Biophysical Research Communications. 545. 177–182. 12 indexed citations

Moffat, John G., Fabien Vincent, Jonathan A. Lee, Jörg Eder, & Marco Prunotto. (2017). Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery. 16(8). 531–543. 571 indexed citations breakdown →

Schlierf, Anita, Eva Altmann, Jean Quancard, et al.. (2016). Targeted inhibition of the COP9 signalosome for treatment of cancer. Nature Communications. 7(1). 13166–13166. 125 indexed citations

Eder, Jörg & Paul L. Herrling. (2015). Trends in Modern Drug Discovery. Handbook of experimental pharmacology. 232. 3–22. 29 indexed citations

Eder, Jörg, Richard Sedrani, & Christian Wiesmann. (2014). The discovery of first-in-class drugs: origins and evolution. Nature Reviews Drug Discovery. 13(8). 577–587. 328 indexed citations breakdown →

Waelchli, Rudolf, Birgit Bollbuck, Christian Bruns, et al.. (2005). Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorganic & Medicinal Chemistry Letters. 16(1). 108–112. 121 indexed citations

Ostermann, Nils, Jörg Eder, Ulf Eidhoff, et al.. (2005). Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor. Journal of Molecular Biology. 355(2). 249–261. 36 indexed citations

10.

Ostermann, Nils, Bernd Gerhartz, Susanne Worpenberg, Jörg Trappe, & Jörg Eder. (2004). Crystal Structure of an Activation Intermediate of Cathepsin E. Journal of Molecular Biology. 342(3). 889–899. 26 indexed citations

11.

Schank, Kurt, et al.. (2000). Ozonation of 1,1,2,2-Tetraphenylethene Revisited: Evidence for Electron-Transfer Oxygenations. Helvetica Chimica Acta. 83(4). 801–826. 10 indexed citations

12.

Ali, Stuart A., et al.. (1999). Transferrin Trojan Horses as a Rational Approach for the Biological Delivery of Therapeutic Peptide Domains. Journal of Biological Chemistry. 274(34). 24066–24073. 19 indexed citations

13.

Heilker, Ralf, et al.. (1999). All three IκB isoforms and most Rel family members are stably associated with the IκB kinase 1/2 complex. European Journal of Biochemistry. 259(1-2). 253–261. 41 indexed citations

14.

Ali, Stuart A., et al.. (1999). An antigenic HIV‐1 peptide sequence engineered into the surface structure of transferrin does not elicit an antibody response. FEBS Letters. 459(2). 230–232. 4 indexed citations

15.

Eder, Jörg. (1997). Tumour necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all?. Trends in Pharmacological Sciences. 18(9). 319–322. 130 indexed citations

16.

Csonga, Robert, et al.. (1995). Purification and characterization of human deoxyhypusine synthase from HeLa cells. FEBS Letters. 364(2). 207–210. 19 indexed citations

17.

Rheinnecker, Michael, G. P. Baker, Jörg Eder, & Alan R. Fersht. (1993). Engineering a novel specificity in subtilisin BPN'. Biochemistry. 32(5). 1199–1203. 35 indexed citations

18.

Eder, Jörg, Michael Rheinnecker, & Alan R. Fersht. (1993). Folding of Subtilisin BPN': Role of the Pro-sequence. Journal of Molecular Biology. 233(2). 293–304. 96 indexed citations

19.

Detrain, Claire, Jacques M. Pasteéls, Jörg Eder, & Heinz Rembold. (1987). Morphological and biochemical differences in the abdominal glands of Pheidolepallidula (Formicidae). Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 448. 2 indexed citations

20.

Rembold, Heinz, et al.. (1980). Inhibition of Allatotropic Activity and Ovary Development in Locusta migratoria by Anti-Brain-Antibodies. Zeitschrift für Naturforschung C. 35(11-12). 1117–1119. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact